OUTSOURCING
Increase The Titer Of A Difficult To Express Molecule
What happens if you have a promising molecule but can’t engineer a cell line to deliver the titer needed to support clinical development? A low process titer may render the molecule, such as an antibody, too costly to manufacture and unsuitable for continued i...
Microbiology Testing Systems Maintenance & Repair Services Plans
Watch to learn about microbiology testing systems maintenance and repair services plans from a company with proven expertise.
ICH Q7 Good Manufacturing Practice Guide For Active Pharmaceutical Ingredients
The ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients is the most commonly referenced quality guideline in pharmaceutical product and contains five segments. Watch the video to learn more.
Biopharma Resilience: Bionova Scientific Talks Capacity, Speed, And Agility
Bionova Scientific shares how a CDMO can offer biopharma companies the flexible capacity they need to meet the growing needs for medicines today and in the future.
Increasing The Reach Of Cell And Gene Therapies
The cell and gene therapy industry is rapidly evolving from the perspective of “can we commercialize this class of therapeutics?” to “how do we reach patients who need these therapies?”. However, the promise of these biologics can only be realized ...
Scale Your Process Directly From 3L To 2,000L Blindfolded
In the biotech industry, you need to move quickly and use resources efficiently to advance a drug candidate into the clinic and ultimately onto the market. Being able to quickly produce a batch at the right time and at the right size is essential to support development an...
Level Up With Product Characterization
In the race to bring a new biotherapeutic to market, unexpected obstacles can slow you down or even knock you back a few steps. But with the right information at the right time, and an experienced partner to provide scientific, regulatory, and bioprocessing guidance and s...
Reduce The Level Of Host Cell Protein In The Bioreactor Harvest
Host cell proteins (HCPs) are an inevitable byproduct of biologics manufacturing and can have an impact on product quality and efficacy as well as patient safety. Processes designed to remove HCPs from the bioreactor harvest must not only be successful in achieving accept...
Combining Expertise With Best-In-Class Technology
Members of the MilliporeSigma leadership team reflect on the longstanding experience of our BioReliance® viral vector manufacturing facilities. Our legacy experience, alongside our brand new facility and latest industry innovations, ensure we are a preferred partner t...
Release Your Gene Therapy With Confidence
You are developing a cell or gene therapy and now you need to deliver it quickly to patients. But first you must make sure it's safe and effective. That's where we come in. Our experts can draw a testing strategy for your specific product, process, and goals.
...
Accelerate Identification Of High-Producing Cell Lines
When companies are putting in place an upstream process, a critical step is generation of a cell line expressing the protein of interest. Unfortunately, the search for the best-producing clone is often compared with looking for a needle in a haystack. Watch our video to l...
Commercial Readiness with Orca Bio's Dan Kirby
Orca Bio's Dan Kirby has played a hand in prepping more than a few approved biologic therapeutic candidates for commercialization. Equally important, he knows firsthand what makes or breaks post-approval commercial efforts, having played virtually every role there is ...
Explore The M Lab Collaboration Center In Burlington MA
Our global network of scientific experts, innovative technologies, and non-GMP facilities, empower drug developers of all sizes to achieve manufacturing excellence and innovation through collaborative exploration and learning. Explore 1 of our 8 global facilities today.
How MilliporeSigma Promotes Quality And Risk Reduction
Learn how MilliporeSigma’s new facility was built with quality and risk reduction at the top of mind and its experts have the experience to support large-scale programs through commercialization.
Collaboration & Expertise, The Keys To Efficiency And Scalability Across All Modalities
View this video and discover our global vaccine capabilities from process development to full-scale GMP-manufacturing and in all modalities.
Thermo Fisher Scientific North America Single-Use Technologies Capacity Expansion
Thermo Fisher Scientific is expanding our single-use manufacturing network globally. Some of the largest investments are taking place at our existing Logan, Utah, and Millersburg, Pennsylvania, sites. We are adding space for clean rooms for the manufacturing and assembly ...
Partner With A CDMO For Your Biologic Commercial-Scale Manufacturing
Discover how our full-service biologics CDMO can help you navigate the journey from clinical to commercial drug substance manufacturing and provide tailored guidance and solutions.
Thermo Fisher Scientific Customer Testimonial - Libbs
An overview of Libbs product portfolio and how they benefit from Thermo Fisher Scientific services.
Raman PAT Platform – Model Building Support Animation
Interested in implementing Raman as a PAT tool to monitor your bioprocesses in-line and in real time? But not a chemometric expert? Our experts are here to support you! Watch this video to learn more.
M Lab™ Collaboration Centers Video
M Lab™ Collaboration Centers is a network comprised of scientific experts, innovative technologies, and flexible non-GMP facilities where you can troubleshoot your process, identify efficiencies, and adopt innovative techniques.
MilliporeSigma Large Scale Capabilities Tour
A detailed look at MilliporeSigma’s new BioReliance® viral vector manufacturing facility and how we have employed the latest innovations and quality systems to deliver best-in-class gene therapy services.
Selecting The Right CMO For Your Gene Therapy
Find out what criteria makes a great CMO partner and how to know if it is the right one for your gene therapy.
Factors Which Impact mAb Process Scale-Up
Thinking about your mAb scale-up processes early on can help avoid common pitfalls. Cytiva’s Fast Trak scientists discuss factors that can influence a successful scale-up outcome.
Discovering A Unique Multimillion Euro Nanotechnology Facility
Dr. David Rowe, Head of Manufacturing at Nanoform, provides an overview of Nanoform's manufacturing capabilities and introduces a new, state-of-the-art nanotechnology facility.
Optimize The Formulation Of A Monoclonal Antibody
You have a molecule of interest and need an effective formulation to maximize stability and minimize aggregation. As with all formulations, it is essential that the buffers and excipients ensure stability of the drug substance, be compatible with each other and meet regul...
How To Generate A High-Producing Cell Line In Fast-Track Mode
Cell line development processes can be quite time consuming and labor intensive. When our clients have a very challenging timeline, we can begin process development in parallel with cell line development, further accelerating timelines. What are the risks and how do you m...
Thermo Fisher Scientific China Single-Use Technologies Capacity Expansion
Thermo Fisher Scientific is expanding our single-use manufacturing network globally. With continuous growth in China’s population, we have seen an increase in demand for human therapeutics and vaccines and an even greater need for investment in public health and saf...
A Dedicated Team To Safely Store Your Cell And Virus Banks
The safety of your cell and virus banks must be your top priority. Learn about a team dedicated to the safety of your material along with their related services.
The Journey To Safety Through Viral Clearance
Discover a simple yet powerful solution for getting viral clearance studies done safely, thoroughly, efficiently, and on your timelines. Learn how to free your teams and trust your project.
Building LEO Pharma's U.S. Presence with Brian Hilberdink
In many respects, bringing an established foreign biopharma company to the U.S. market is not unlike starting one up from scratch. In other respects, it's even harder. The job's not for the faint of heart, which might be why the Danish company LEO Pharma tapped ve...